Also this month, PDI announced Heiner Dreismann, PhD, has joined its board of directors, effective immediately. Dr. Dreismann is former president and CEO of Roche Molecular Systems and has more than 27 years of experience in molecular diagnostics.
“Dr. Driesmann has been on the cutting-edge of the molecular diagnostics industry for his entire career, and his experience will be invaluable as a member of PDI’s board of directors. Dr. Dreismann’s extensive industry and technical knowledge, business acumen and ability to effect change perfectly aligns with our long-term vision and strategy for PDI,” said PDI’s Chairman of the Board, Jerry Belle.
